Table 2. Major hematologic parameters pre- and post-ferric carboxymaltose infusion.
| Control group (n = 12) | Single-session treatment group (n = 33) | |||||
|---|---|---|---|---|---|---|
| Pre-FCM | Post-FCM (after 8 weeks) | p value | Pre-FCM | Post-FCM (after 8 weeks) | p value | |
| Hb (g/dl) | 11.8(1.9) | 12.6(1.6) | <0.001 | 11.7(2.2) | 13.3(3.5) | 0.006 |
| HCT (%) | 36.7(5.5) | 38.7(4.4) | 0.001 | 36.0(6.4) | 38.6(4.9) | 0.003 |
| s-ferritin (μg/l) | 141.0(195.2) | 438(311.8) | <0.001 | 63(103.6) | 274.9(324.8) | <0.001 |
| TSAT (%) | 11.8(8.7) | 38.2(13.4) | <0.001 | 11.4(4.1) | 35.2(21.1) | <0.001 |
| MCV | 79.3(11.0) | 86.6(11.9) | 0.005 | 85.8(10.9) | 90.7(9.8) | <0.001 |
| MCH | 26.2(4.2) | 32.4(19.8) | 0.099 | 28.0(4.1) | 30.0(3.5) | <0.001 |
| RDW | 17.2(3.0) | 16.5(2.9) | 0.326 | 16.2(3.1) | 17.2(4.0) | 0.212 |
Values are expressed as mean (standard deviation). P-values were calculated using the Wilcoxon Signed Rank test.